Health experts deny link between Ozempic and rise in suicidal thoughts for users [MSNBC.com]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: MSNBC.com
agencies in the U.S. and Europe say there’s no evidence that thoughts of suicide or self-harm are linked to the popular weight loss and diabetes drug semaglutide, which is sold under the brand names Ozempic and Wegovy.After a nine-month review, theEuropean Medicines Agency concludedTheFood and Drug Administration arrived at a similar conclusionpreliminary reviewAssemaglutide rose in popularityreported suicidal thoughtsAs of December 2023, theFDA’s adverse event reporting system“I don’t think that we can say that the question is completely closed, but the evidence that we have so far is reassuring,” said Dr. Eduardo Grunvald, an obesity medicine physician at UC San Diego . He consults for Novo Nordisk, the maker of Ozempic and Wegovy, but did not speak on behalf of the company.Novo Nordisk told NBC News it “stands behind the safety and efficacy” of its GLP-1 drugs when used correctly and taken under the care of a licensed health care professional. The company said it will continue to m
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- How expanded use of GLP-1s could affect long-term outlooks for Eli Lilly and Novo Nordisk [Yahoo! Finance]Yahoo! Finance
- Should You Invest in Novo Nordisk (NVO) Ahead of Q1 Earnings? [Yahoo! Finance]Yahoo! Finance
- UPDATE 1-One dose of Novo Nordisk's Wegovy back in supply, FDA website shows [Yahoo! Finance]Yahoo! Finance
- No belt-tightening for obesity meds with market set to swell 10-fold [Yahoo! Finance]Yahoo! Finance
- Siri's First Head of Product and Design Launches Proemial, a New AI Startup Combating Misinformation [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 11/3/23 - Beat
NVO
Sec Filings
- 4/26/24 - Form 6-K
- 4/25/24 - Form 6-K
- 4/25/24 - Form 6-K
- NVO's page on the SEC website